yH?_k.1!Y&@\&MC7==4j$[xޟZ0g&$vT>Hi%tf &½j߄yh}xCJqӔ-JE7wfIa-]w2*)U]yT'M(ELra)tG?U<Sm݋Jzu& %d݅X(m 6 :sM'!ܴI֒Hix,s߼{҉؄VE:.ݴw$˳{6>AY`6~--kvUɑTlh4uy?1 V{8{T/o\Ow׷?/?'e}h_~R?y[ЍS:o9?WlϮS烫)~~Ӽ;"}Ac}^/?WG4~ ͟?as{_>7ǫCwVͫ2R<}|4Ȁ~YZ/y/e嗗\~_7//ljlWgoVcU__b˛ZϏKaǕտ7ޫ/X_/[իWV_AtwMn%Uo?9s~V6~{}9X%G^}OϘ'gzsT(y'wj<z';>,gorfFx>%ʛku |ӛw 7 lc\eq#zq*=T"jYӧn'`ON9KkI?o y< xi8OO//>ǧ! |{}m=5x׫_?;`/>5w^ׯ k?+xNwƐ}J="ts~ԏs},, ._=+|pc,V~ vGj ~KStkþ{QUG[y{Ta;|+&N8gOsJ^9{<"ٛ7WW 룭7ٙ6#^O ~ڙzz/_4]¶柦цG˛^|Y^?D S>xQ=]?4[H'g%[GͿClzHэ)o3}z R ~0{hد]MBQ?\V?pU{*-߾au{_BӋ6?2~޼??yg^>㏿?o>GpM//^?l^֨5! '=Ԣ\߫7BnX 4LAW"Ǜ7_7AKHOY9.?:~[:>ow7r >\O@|Pk}S\ n.TD '}%t ȷ@^QƣWo2e^Y)$ B>BqÜu7` 泞I}Ds^ M?zG~Cx_KX ' q?H_ŸWtq?n>_>yyA0?%l9H$|F993!J_z|!7 ?͟'m<oc—suC\7AܿT\Zez{SjZ̎x\! ?nʝ[_|o~epsߞl^eO䁟㠛Jz[i8Ks^=E]8 $7>?;ӷRP~k @Fv1t Lߍ}ק@A-}hG=5hh;$?R|pu8BJ7k߇я g`ʗeTH+y ܾs=hstݮ`A~/b//{OȃCW'*>S<iψp]1HWH!~r|w>ޘ,^CC _4 1ŎGRs#: v,3~z Y%7iNֶnp%BɀC ny޼Cts W"\} tHሿ!E'oЉo0PY w<<ݟ*?|ȩ%E2 $=jʒpt<_ 9;)Ns]"|+D85w@Rg^zW(S zdݿp*BOo ?zp k:^9J`6P mo?{D)oOL=L ?^}v$zѝOJVk4\O|[ nŇo?%[g>>hJdѶ:!w:? 0#/6#5@&o\@N{O?_ӿĵQB4}Y|F ֜493W!%3N(rI8)4)v_R{aJ+tB~Аiݐ!AInn4|rv3c V=lZ3 (""jI%Tά6l/9.%59}_ kwVMdT.2G91T*NYnuj|[pۻYCi϶z[@W/gloj+vT;} :WoiicA*s:  k.hcO V-Ȅ(cLɅY!f@XGlm%"ݔO@lY27<ԧ5%Z@UUoBwH$ 8> 4+y/4VгPG(;;'XP?n~1^ϱ<ɓ^}n{ z;m{|ހ]7:no/3d |:z,U 5(}@ ȴH ^|vԬ(aQu-~ьM Ur}GZK rF7@E7kKF ؤftq:.[9i/+ JrP>3xbk`Ez|S`3(Bb5Ձ^b'@yAwD?"JV5 [Ӡ ӧ̯ڇ+'DSn~TQ{T%o^1#o؏]L:o>A=Q3,> D?9ǑR^Ԧs0stL |wICKiߐ[>|F"z`v ʥy|օ((dǂP.Cw }p /8~|~c_/W; ҏ?^ic, \m,~n~{~~ہi?h'8p]_ ~$O,?\.l˗ՏuSa~6 .sYYg4<]}_Ug&͞/L|T&XEs,bCS 讵>¸6p=o$c>௟=yPNɌ2ZF t˺Y:~{LIU[Ukz6o8ުj\2Ӯd?AL08cH(<__]?s#AJߌ07#w|uHt&/*4,̻%',{ l/8PK]{+37t~}ֵd>dnOm7EC Ĵ8F!Rvj7sɅ*e譢“d^qVk)HLyv$Bq9eíL]oo9Ul:O {MXaHi]4U3p4ܴZԯe ?V[X3WL%AoEOpa/`/vs&髌$êj0ux"vI;$略yX=-u*ʺ'JL7L,`"[[ q>[]^ć7bFhX&$<Tjx:ZT=hD$M:-5,qaX.3 g$L}Q7K8> ÙH2at1=ZK7W{?J0쀆HQ3'I][m[4T;>Ey_^$4H:S ءɴ|Xz_wVyA:{')/ i^NvK0*ܞ uDҪ#v C=;{~H%ix `@UO  $ZB[pv!>,I?Wt/)Xo|K[ͻo*v/ Q| np :iۦ~j;ࢀL{ >dѱ9#jNsoV`w$MlmڴV\ qITt kJs׫44UjFٜmpnG+s?ԦW~xLƄa$pփRkHd_ %3>cY:sr7ׯFZ"k-pp^ya$6bM=Jden_3.{O9m¶5o{p0~NS7^i;Y#a=o%S t`oKӭt3Ik}[EI+Th3^Nud`ns=2!I;]m͒j!|0֪j4g,nh€vۀiCa皪\R? E並jr,=n'[{ \}'k}i܀aO)Y]- 0׌ WJE ǹj:AG,6ܟ8L0 9┾RL}xF~K2=]t6lnWv:vef. 7Ra;8b7h|g*k Z3b $ 72$LqǦ+7 u[9޵aQ@*B!nzQaqͣn:sUրt3~su7(_y z KNu SQO⯀A+)uk^@tʶvk9ȆwB'z*'кsO{߽GaH6i. (u,o+Оwh?ަ+-;z *@|Tx+ Ԡmz}TR ʇ` =MR'DhíBƠS4&Dg-]5]<Auaou[h%>*ۅ~X*7LB.:K  =g-\yCը 7>/B6Rmom(*?%CS IMI7K _7Q?b53Mn6(YCvKA[/} Y=驡ĻD[aF'>p58G-2'O<&Ӌs'^\3Sm}Na֎D2?ʹw;#a=SSP|\)ZgG_KvRW[hϴsr#8&JO{ciQ 'XM[(8n ]gg3ОLt JCT %#Z pw!bU陿eqlVΟe&F;@n7eZ玩|,frkfm*gh崕ۍ:a+u7Zܷ.hjZM/:<֊-̳W?PNT h[EWst# LqxͿν/4 vr.d7gAsL|n=“> ck犅-4"݆RQ6,D]yCRovm{ғb7l\NvˤRL_N5\PEF(m2V<^#v v ^8<\NuDVk s#j_s3+9򢱌&2Sg{]g}X% IQVYH *MҎ` erHnºpJ`쎉En@bq .<<2Lxh)7G*2n#,s @Xɀ**i9XaԖ"T8iR/ nSp3f YфRE^ ȁQ$?"0E۴\4hCռgt8^QM簶fnڍjClV]@"+=kecnhZ,l\+R6(uOz嶓hBXGdYmOۑE(wm$q{1'm=vQ]}Wosb :X!_ cY#y8D %TK.F\[_ $KٕN phBx!5d͚gZlec)ޡPje :0C;%=&ﾤM$m6Q1f=ٙ?S@IzAs6h9"8^ H CG;OZUQߘ ;hB8zP0"p:D{3  ®4~,eb/""|mu:ю)Go@Vap+$LG/jeq#ZkC/D8" mBww `D<FjB QdėnFLQwi,7ʁIe1 '\Aʪ:Ev׭_rq;+]sC;&Vo0bDH>/&DwnB= .%`dpcM*T~LFz) ! 6z#u4% T- k{"!6n cmp0鶈ttsnuwKϻo+H8}7ds;0.`Ԙ 4OǶAyYy wkg>VS&ەU1o&ʍKMatRCg r.΄ΈC[Npf>L!8X.aT]DOڪ.6\2\ߞ0~&H*|gU'A쁊kߨ*Pq#kk˝wUU " gq]?.:R`Q<4y rz>$潴Đs1 ^x]h9n0`+CO>0K9un#k_Sy$̑J|zF={$u6P=!Xe;Lmza4Tg4L %1nxxz셪 EfT*k(ԻE8eђΟ6ss2Zw@_UlT.p $nK;;2γlu \Rmw{.Nc#SMtE(FKjWBVDU0e,@eZ(!!KvJ_/pҟ@fy4A6DoGccKH@LJq'#~d͂c ],ER"B zӨmy.ι@Έ!^Zv[}HՠaD c߱?h>WM!Ke[=6GqUn6q((֮hDslc1"MW95qUͬmߢ z[=l7_lsG#:8´gc2d E[/Ӥ#)m`Ns#3oh(-ͺm^j'ĉap |ɴ͔@4-Um{y{jr4Hgd|GI\,W*Nԏx7:Lriv9A蓳H}ں)`XMYe>1N6[lf;;~х%slv\$j _-t%2dsּj5Nr{n`͎ >@YZ(#c=)`b/PpVwJԸeƆ]表 ]bPH!e 7ff0xH"4HBWT T?|a}a4>(tB=H|vԈeiL$>o1u4p[^Z6cC;[X|ؙB:4E+#O4[E^ʪ+)`j@2Tl Pw8iԷ33f7}9ݘҺZ µ@"gӠZsw $\ȏUWF+8..h0:py'yL{Ʀd7faqxeF,B0EX7;&j#}osm im;>ܚEi BqQjC݈7r1$1#`D!>"4Y;9wv6hd+iKs8fQ/?cx*l?x`TeRE\ O(Tys{&h^[e%P! )zY?ALsCd^ck6& "q#<cQؕ~[0 Z(t9rH`A/G)5NN9@.irY3[j%1SUH,t;hzSGyg0HSh.Y: Maieo ^+J ?gA) }8ۣ!BNmuIh#X4_v$hߙunp) %ja s?eCś0qWe fVd$"?;VDW9mm;Ҷِ)Yv96Pd\ٌ_ P,\ $޵ke9Q.I* 9jFڡҶ*"2ku ndq W]DNU>+7\kCCo}qaC8Nq};'D2(uWE@Ȣ AuйVԡ RỏSoQV v=JRQǢ^6Q[qHЅnb(c[]eI1&P ƈ㾔Nŷs+dyE90!{ LeFy~L5x,2$%UOElJzGY]NzEЗjfa9=KCʳiߗyNABݺ:Ll"ڂY5kݪq-6,f۝O-@8'c[u =A#ql?C_5a0(8[B3GP>pmpC6K$6f80>]Рa̻G (f9'F00\]LfDa,n,ܼa]~xkKە<7ж@uu\4R=@ar[HL1!&Ns)A1fz% Ld7pq8z!/Ҫ}D$xO&f/~s,j :m`NqLz7(2v o0*aЖUyeљ&`r̍O4;40= ށ&L"})^Y= yV=J<-:B7*_QyS$B@#q[p8}nGNE 57ktV0k#m&."wSXAB8jl(1t?Q{ҭ?JںsDxf !x4KPHwz@a_v7 F~&#a-R56]㠮 WL#6i's $!w'U5uE~D@CmV { kض\aajmρb9Z:+<HuM;e—tԌ ،9.\,ӶϨ {KPjdkPf y -*kӺ#/&uw9 s&eo`4_0+η :,(-<ۃk$CQ4Q>ou2찍bw  w6 k54l^ޱde]9 `Zv`ኅyE\p]8tS);3M O!p?VeztA-uN!D "x&9֐@S~3+0#mV =]jZ(N\ql@!."aj)=$&B 'wM?N$78Go!W`‘ 18YpcF(z u NMGX${w@gCBQ'qw[MѾxS,æ; (Buo]kU,Tų|y,*:p=|' aqx2-W}w F/.>.Zu!gͼb9b]FN.èŭ"՛_@IMvfO?dɝ% z*caL"3((0CR̭GVXTDRUnȀaf~jR {f{H$ܖtkorpYS+PH.F `Uxv 4 *G>TG eexqndw{!rwb+ D gr4ٜksn!wt?jm\2]ٖq◠l dqd"Q lB̴;mE^ſ3;/XnmC;>:W5‚:+3%@%0N:^r˵` U$kUBA'D/?y^zƈ[k7 pL&j)4_[Ѭ8&Kb88]jis;O(= tliʿts\`>4ei7 O3ԃ ) ȶBI7a@PE-fg̜q1cuۜaq@#@eA yM7P'ɥѸVw /7v%C$֗ǂ ދJ]HF0hQr$GY4Nseٵ,ҁWFgcЖAiQ"s?zgڡ-dK*Qi]V.~,:֝4Dk$Nr̸>=ʳF XX`KV>`pĜ| |fIevBzV0[f:ufQtQǑ:P[E_+z:!'n(Vt;Mrܶt& m4 T4be)^`* G;LƘVC[WfYCWpY#Wą/W!#rj3V.X4co;Ļ/Np1~[՗xVY46 / ׂJ>|zSm h9k+Z1Wa=P UpI5F٩_׭gz%|~0wl4Yeu)'s60b5!.w㰰]w:6#vK$6M{ #SVn Kp abXH >I sK|fS}*F@3۸{ev/1J/I>78F\Jl7(g)v+G M0{Ux8#m,iax֕.E|DhoѮppcYsFg<4!1B#1b>Z4,? tƁs {-͢a2Gx4j74N qUulbP8De'-UHI<|dKWö޳7`r5J6x"h e֡I[T!D ,EnJ"Φա6Cr"x\zI8L80 y3Sd]ϩg_Ta#kһYo]]\cl}%f1|:."#+|A^zQMÍgz=խO޶.%xBX(.Mؚ䖍K *u?!JH )fOX$$ T0S :W0fٹ 19CUAFUn}_UuHߘfSZx@!/9aḽ`"tC"Ǽ1O#ḃL58[o.RtHfuǎwHgYIYwSDⷼ|,Y&!2p_M~0ԘY"AV$鞤8pSt5`*NY4PlSDPivc_QV0p-i:Y_7lA;BS4 .wjY:RRTa:̽p&Xۤ@@C˥UF^5+th ؽ<(H/}b,嗎]$'h$FAT{o`6#sMæ+ɱ jE )H4ڝENY(xS7)}X}TU*dt}:qAgF(!1'6W{ IM$ cՠ0^.:A֝YN3Z\ `sIBV#)V0\\}$U[ڇ+%;]N 7d̻/HYy;a!Qҙ8x6Iŗ ݆N #?Qgj>oAwGܣ(YƌBNX|7*'YwܫkƎV.O-1X0?"ΤLZ+ kwm evrW4$Z-jh7~9 X/9mIJ9;.wwhIly 4gAz!'hYMn"%骨5nDY9%JlVE,sṪ#舷Q@+(A7t7ac_>uh:haU҉PO~U^@1Vv#WloNniIC/{pj't2-b7 ۉm`sݹ\G2 3%!:~3kƙuwzpBU r1>t !пGl%u#q#F258!JREQj:Sa\ں{l!@' ` SnCefg+v=p6ňE Re&[]cŊjuu76q;}+g!=#~u6Bq-J[vڳmI|ф3f jnxėtSQhZ싔s@>"1y\c[0=:XWm(Y+7@BZS  8,B|%>ifWgj(A+ cZс&T"raO(-(= +]mWvۭkyivT}KC{4"|B^=`oa^(Ṭl;Hآjgc*Vc#hٳZr,ɥ00g˛Y  Q3:QYI_qHF+<>bU,i0FT, =.vat:4:؋@"( l)Fhy^ĜGh=33n.k6z0}R/-Dæ!⧨ƤO#nR1DɁpp7(;J*XDoCDI$2A}5\LfPA. q]_QВtX&@O*UB(1 d#J\s%1aN92hb9 Gc[HH9-ըC!pj6CTfzި2T3$31<t^x'@os׃ià;I ҽ : R_Vh $CAryV%[[P0A3YN\\׊lT }saݒ/$N&dyK38⇌0]v[Ūb2|-(Bwp~UpОjkӚc7lD@\;jՉZB5uq6c*tQ;܄9UVd Wēy0%'QDc &6-ʰ J0&:gD2-XfIu2wO`_ 75٪Xqn#[b9u( "h >q&%Uц51NW٨S.UXm˻G|[k)E1Wknp@(P!\ €?=jD̞ Rg;HDUǦvRT]3#tcv6NYc_C0GhW)GɤiQt=\.7dmN8 ~&HV3X3{ћX8CW;~yc̪(0ĎD觪hKM`~_ =fo&<$ѱJ㊢%;hQa^@3  e\T*W5ŀ L;:p۪KH%Q]$ĦG|E;{<S1z$3\Zb`޴E`8;f)3rL^>+OI)6D\}xJoݶ)\DUʴ><(O"YCQGPL$dE  5"񨰔`d Qb6SNJǡp0eWE0xq+/*ɹ;q_rROcZSe׸^ڮCgK1:)H"_}^.h;v(cbȡI{Rkw6rT9jN+[a B5 ]^."#Le6`aqXi`NƔ,=H6PJ C/UQamKαþ)R_[Ym`q *h-Nj ˃a(^ "сBwP8pc$3Q &}AfgB9ٴǎ -5IdAeqdX s.4fwUmC{mLJ 9%I<$.E}\-L1jS)'"0N0^.ns!b~w[$ۈ 08P"lCliU߅k~arоAz; ny*cLkZ0"GUTP^95 \ztxh\g5CBQeѷ+%>vGrFt.n0+2ñ+ '|VM=c ^1 -eju~3,ٸ{8p:h;[v@֍cĈ"xWɜZrnsJFI*DXGkj̛fA] Ԍ]B5#q8`38L5]N׮图 WG ,v  `g#/>+WSrX薢4<'wVRMHKHoT4@DSH!|sc+%n[)h .wA݆V1qbӝ(b$%BIUAXp~i6]*=EPFUyRPbeadYt0eH";{Dӝb_n֍ijQͣuUp R6)tpc=Cb6MHeȟP%1&LXgUSc_i,h0/$n훢b3>=,Kkn>2&,⩽GX2ﷶQf|`? @7 F搥`^D %>7KpH5VC$C?_.yٕsA)jKcD5`#'Ac*;Sٯv[)Ů(\Rix˜ftq8k%B%NZ崉64 }?X>_2sdEKMaÿ~.wݧ&'eE (C{Q:UvumYmeV[?4-ɃKURiIcGo y6\D{ *^2ٓ3;n[i`9k4yH5YFxlc#N刴.׻ī!GxD}_F9Z4F-dx R(,WÊl)ZL8G5`Ckb:ivV6_=Z}5.0Q^!N|($gbP.rLGW@2 yu&BJ}G8>`Y,Y;3@+0M]-ӥi:Lq ڕ,2ɋ9eu\=+q9`FXh΄ux0z!! $a%dqOJVWZY_"x‡~⅗ӕFmL'J7kP-x+_&+f+a,Cd[4qQ:t>dˈJ'` (-cpV50">QV:D"d ʒ{?‡$sC*,:&نBV|c, xd0L -w^jT,SPcD 2G!Ga TGg:}\Wjj}i\{K@z@eЇ}Ef= ,hG$I_+cs:VWtbEes6_(HzK%͢U0ψ 4~ ,5IW) "&ܜ ڇW%A=nUخ):RmFpŷџ*ydc7:3e3WTv Ytz.4h&9g~3 JmmșDYظvPpj8>a\PW%f4[LGBs'[ C =^U k]' & D$b퐀11h{:f>|Qi>g`09j*j-Ks_ Uhl[4BUIxI2;#*9lS_PucMr?k4ܱa]6*a. }l>4JZ\%ӭ@t D$ܘRŸw܇aeՁR,30Խ¾ 7 ,a8=POQc_-1svlefpȭLVzAsSM AZAKSϫ׻-x @ᣀC-Wx&P Y>z"B)tgpLэ1#vs-.hk߁ujKK2+Q_NWrsQ,M[>Tf'V1g}UK]|f c@O mNePV~wjpwMQ8e4}Z|z)Ѓv/@E/dWO$tznX7u9 znTM[g1}UL7]\B=yu|>]^@|3A<?\(=y1\/qi~._q"8(0 cn7r9]v\2qFm'l+8iʳ 1JܕdOWS1& de"UgKw@*XvM=x'W&@Al/ %뤤4 P P.?^יy}@XV2M'w$'$A?UC%M`ȳdXعA0"k24h wCr)ZBksEoz"fmWUsL\RLj[imѰaDM̿-Ќ]1Ks.t?,.6 6_x- ҙa }| F }(h9A"z|qSAU6OTN hyiB5QdI ;ZyZe|hSSzآCc.!}%n.K8\-Çg >yYh G4RdX&3E*ƠZ"ܔ{U(AJYemI}#GԱXHkOxl*(C\.,ֽiH]bkQdײt-6ubLXO9o y"a[a!&0+w@8%Bg@(F_k\1Kf~rtzekBT&\|xo>1L:@@hUz/ wǰ(~Jƒo4bp+:Fæʰ4b9 Τ!xKA:`i;]F6VV;?YU-.üu2Yk[OZ}bFV&>[Qƒ]DE\YVu߷/RB_Kg:S}.-u So;DagCbY9C( sD+VLfnef!5b0\x\OqA%M^Nrbkak@!Z6n͙/k":=f}5c.f=>!l}iZjM][r#2ݣV,V$xvRTr9{wɢ15rk G߮9}Ch`,޳b=h3F3pK4r{n93c݌]!0ayAJ& N>Vx_@nj7s9-צf;Z|U/Alǐ c.ǀb' $$h06y$M^bzlTe{(>~1לLM9%anX^ 2mVj\,DL#G܂ӤPy-<w Y\b2#ң"D{\p[7U$8-`~A x.֪V=vrfjKTI#K*swLh4;WZ8 E.W@פ+om{amZbm[Fć,+sf6J_TL%ڰwHs"ʐ3`e3j*MJEK NzVenxꍢq r~0\?~\i*0LLfRIh3VH_#\S9C6L&v2-JheYnr!aP@9i7a-֋^;Dcˠv yW@Ոscgpd?dqR+QX ܄f9&D8 ,yPC`198roSQ/*FԿͽ)ehg/]T 6=+-;bacmjΘ[2MXvcΜPa=ncsXrPCkƤ"vN]B1>]z%| CL Z󙟚j%0aw6[X W4 ჈R ˄bѐ]g_7_g=ui6꣠W]6vkKEɎ :tQkXt{4Bݣ5Ӂjkdyiz_&q?9d6SLQ06 0A?d(x>xѭAį$pWk=M¶.G+"@a|I5I,_KW>YNq %z] & W)mUb3ŅĢ~1|"G.)Y"}Jp2 }v8h́l4:_[WLyˀ}:"Δx5Uj\ʥ1 br#o5PS?F)|'va!l ix fhC8oTM63$üK%~w_ԄNŮG5m*Wu͹Ti`/^TV޺z_&k"E{ z!P_I"AXpZcXƲ 7&!vgU )m r;qٸIOiAힺ~T;`LQtbhc$s*S:dOi h:/d P(Σ1ӗ2U'BLôY+fb_@uת_iQ8L|lMoU8k%6DxvqP0Dz)gb`4u[Pźɖm oyyQH,h@ijez&lR;Uu#*`\1%$BHJ DFD6s C K ĉbWi_Rb/py<:kV~LEHr *1*EalX/ q` G8kE'TDա7#iPO|u zE(|E)hߨfľy) wm]iapʔDS̄؄<|u.h*:,я4ϸa7-I5~&`\bÒԁ ~UŨP|X%eovOP8y~xQFo٢ ӝbYnleGFfw˰ ù=Ћj |Oշv"0+/z&w}Ut՗˓&%)!DQ\|{T;!#e&vcK?ޏd뽵hkgdS 1H-(cG`[U. ZY50w|lnºR6"=xW Յ׎$ɗG$ z(Mvc*ңܵ3("S Znz0?n{I b!v\S 4WBȠ7ø@8L^V>‹3H%t k Z^uئ^"FF6c1LNjMk0i3#ZL?.JZkf[;>l9Q3l,eC]qb{mc}6:bȋ ~;# ?k۾\ID%Dx[)N "8h$ɖ-ٍ•Ox.g.p%\+O ʴ \=V3ofK!E`84 4I0nYlK-PRCM@䳖ުm!g ڵXf IDb\?o9wV=1omVFc$m&աl dj$ρ@Q3= Zk4K G {{{[~]ʑ9aS9Sdj9sN9O8La\b"k@1RWU%:JC8|/ 9<'pRk)a%MʒVp#;U)/*1`|F.HW(  ò&a L4uD}T-m!}XYwrGUo!ikYC)QPitlWPbӦb ۏEOڄdJ.6*ta7U\+w$y_2- O 씈o/pg%zu;}#?ntHFM%,h_И4p021i WJ LU)ǎ3<3v0>Ua:\K شŽˠB/-, (J6izTu0a6ʫ[e9few \ T +25qA,='w? 魙EA]uo D^_t1B}x>b#2MqF憳 h@4sNBIio0>яē7OkX |kGa/Jg bdh 8| n-qi)y#WQ mؘ &j3$yAȶ\> B2=BivcMw+ׯTɬuz_+JOYȈ zX%yEP,>|NBaI/@=]F4DI +.4zh֚(j}fDĻ]xqL,pB1 X%*4On%X,[dZKh0 Dz:FUK#F7&P47EMM Y?^XL٣, gd8tI\DIpiQim-o R,i5afχ]9ZZn];QݣcƧz.ݤm:=áZD;J"Ldhmm$u_܁,wc>:KE*cȌA\dzE?P]q0/bmΌp:4tqIWLl',)+ے- \"=tbIYVKWx놝nFƹc yԋN{([OJSr¤1 FKTDsۯRç;}'Ј d>##)%G'5:ߺq;D,d)˭ZQT&oH'ed.*Vt+ҍl, c?>ëŋ~+2É<`#Ib"amXvUP K-rOE"#\tX Gvluɩ˱x?_6B%P1Fhqpd,\]"=yUontR+AQWp zW5 Ko6ivt7 ?^`\k2attUP)W~"zC<.fhX^np^ ge'4DpB,Y`!05vLC!uNG|F:X7/%E *?̑ #--P/#\A//`m&<G CLw!NT{r-h E鑮}..b]qpRު9^fP$7y FxIi9|WXQlew窕n6f=ڷa}:^nvB 6rҢPLZ!B"w\:ю:5= (n+=űv(ۥ܄8̎6875Z- R,afu hI%c=.z]r}˦fdb0]/L/xdw2HlQ񘼁߆8u1آeFSHԉn hꩩg97trZJߺFqW$Ro#tq$Xo>t(K,CC$ҢXr@Oux8wW?Y9 ÔU5LPm=Xg };O WVpT@q`,ӺUulG]*roA83M/"\ 2<)e)Ѵ)e9Js[utd"Xj{ %bTԵb8Yc~w9\mMlc:羽o^tz~l Pֵ`Cƹz= hYjI>^Hԯ=$r۸zPV!V R2f'[.a ݓ!V9tA$!w PLgMmnZN-JRY% ܅͜!5_Ķ`x8BTW1bL.k񅣖nVN7L-R[vvV׍b̒Xg;jͼMRɯPL+MPŝiuH󣣺4N ƕ9q04҂ ?%oIJ! w\\R샏fCOc{ɹ-&nX^#@>#v0<^(! h8C(L*-ؒJrT1Bg#fI\ UA(vP|@X.gtb7-b bp}0f?:8d]7= u`;J[+J 7!sBQpͣ%O.]42בFP綈6<:~c9*:}9++n%6|AP_EGqpp ^Bp*yߨ^8ou,r-:T2[R~,dy$:6X+N@!99 Gv{co˾ܺᶳh{vؠ&⛋AmtX^D G*?K][ cQRZqsYǙV6 glVV ]p([v=(##ѐeֶ:J$ Re{˵y" Goe kRMް\F2n! KU' 2ܻqtowp:Ô` X6O6 .9c%p4|GF!n HvrWnv|dB `E0rŮdHŕ[JcP_O:A0Vgx;\=K.>TvD{ {KLuJwcD7BRNNUW'ϠJ;}ƨau! mҲgq 8; ֙_GE5k,umhw~;94G>UtWLIN#EG{?"+ʌ{Jm$8[2W4F&_*Ɯ5lj+B(N$:!pu+MN 2waaPHI/qdDHaUY"w [;}d(AqIXz@lYD8 шrtn1A:>Uqn: e09gNKR2rr.a gB9(}FMu( ,]+l簔yb, p ;ep!ڴ-we2=6Y'RVcE_ p H|Z~.?׵>uCw8@;x$Z%l}dF9jE_ +B:qfp88| G縀X 7RmFt]A 8@Bbrt`28'&i(L+Z*n%}x>?Rs8@xA}R/v"HjtUX.: P1K.5RpN뒣oڧ<$ ѸJ =š!p˘qqkO2aq' N$gݵi<' 8#)rEZB vmn8Ӳ,sq0UM6$dQfmE@| Viۯ9?sFm`i $@n6㭹0!Y|/:#,zSIļ{LPSx!we(;(qa#Kds':n78N5c6uR޵:׹ pݻ]XfXEhM:!.Gaa_<$N/&{"f@?&d%Ӱ*̏76>[zim4Nu 4ٛ{n'mnӴh]+ϔfMBmB v(l _r"/.^9օԻl:i 2K= Q,'|IWTz3Mh*٨JFsK(}+:ŊZ_:\CN*6jD_(ITfRʳ '!(9cb-2=l|ĥuS ?B5-V5z$*1e7]'1;Q*~k>Qն3Q|O$|U?>:_÷H0NƑ2BIaLw$hʷ^(C`m£HI;lľjWts=ӝS6Qf\TrZc[9}@\o掞6{qۃ* :lx4~ , M[3oS"pBOȋm䆥tQS78A ѶtZ,|1YW P\!Oa?ՐJ63WnTMDQL6ls3gZ|UtE+CdL.!0O,>/'x`s_. !1ɴе&M/띡f1g藬mG|C\4hIIpr."[,lhKѧd#?ӘݢTDi%F3lVtz,(_&k`An0Q@/E'=>^"M';32EQRi UܒU gsX{l_U HY@ ^`?_T;>#k7×[:ͺJdL tCT*sL҉!n,6Z <@p}ocg9[2͜=8C#\4rUvc1B<;GcFՀvX6ax4(Vs @}$YF\\|Z!%@@ ?& *}&V2eҒ@Ϙc:Sf+!7f,ݍW;bך^n|G݈8|'Ȅ#׶˫<&Flgewx)3y.8ɉ[ZNCx!";th&bv1EleYgU&HBi@&~g>G[8gll4q%pllMd{G c2ڠ:jRҳ˸!H(m . NSR`(%TD/ZC]M~mqDW-}u+.j$MJN9Nhq>BIg|Ӥ6]5\5o۸ȓۯ F҉+'=3vc4F)CkB,akM8ao, E sIAU u%WfpDOȉѾGA ޗ4]oǶPRc $=7J\+#b줢!9 Y=aw!&rr#"1#Yӥnm@@u[fuM'pY͉ h(nuGy(/cQGcC!$7mEr:^#StZ+w=upfdmVgٛywސ7υ?i A -0U;VKw09 1bTٔ+F[ziUG\Ӡ-Z)g ZUڜoh3&d"`hDSc Yc6}„n:7L+B,[!-qt}P PP*z3o1  eX\ FeS3*;7^N2,޲,cMY o[Xw#vMi!TwMfiĩ` _PVnCq %8 1_ `xs"8Zk7-GWܾN"^!yEg1ePE޲M# MEt.бZTH"N63kI"Zhֻ9v£냖/kuEzlZlcW L263=Go:Lo40 '\yB 4\t') Zަ) x*?s8K6 Y;Kq`gZpQ26UaW!2ֈѪ̱ cgUK?9lHeAr\ XUEY1TdXN$>vPs+ XEJ">E EspP$sb}7!mκG76/foƽCY W?P50:FgJLy>ɳ"po =5@N|@ě;ng<.~|.3 ȅS︍ yoR>/'%cN]lctlW? !F5~~zy˅FOq}(O{?]cNANXjB0}dҀڳg%č tM9ٷqLJq{}/}䬎9G=k̇8dv`)COGѣsmLe[w>d23;UWh&-`DPFPifokw}(z6EZ@k26;lldGnVa؉.\hxʗh65GriUfZ]bĽi(!g8a+" ѸHV$Ɖ dLND!vE ͹F"4pFk_2~sRk z00Sll L|\{ >2ώ5Dpηn!&j_+X቏{\mءEbNw4Ȇ(+C꽝m/] ~I,뚃ƨR$AiZ6vdGw.C%.'j ]Lת`} \;I.|=@R A) #*4R}] 8FeМd)&+#vsy$ Az))WFFv֐Zcz/ "' |}q$;^Kaoq8S0{ =~0WLF˩[Y @8bdQnq+1߱" V"?I|/$A(m|#ptE~6ѥ&9g̐x&sy1o:͂ll4XƇϨD)4Bf VcOAdBI$DJi렘U~Dܞ2XI`>3%o8QY|r k<#3Ǥ:Y/4ʍ tյ_YVV`5v,rWVӹX M\**@wŷODNש_ocy1 2$G &g-۝k0w1zitm媨/tRt0Q"Fgf)(k%baF$n*Ye[h1bAd2:cA4,CQ3nd`#.нZHC. aml|p᱃|pEc@ElĪ@TRƌi4J&Q4HȽ̔_  xuAtz0 F.ł)Uq,Gj[ЅAanugI? Ƃj~N4.i$>T)H"4 p! Ӡ//%98{W,pJYb'C[98fIj}UMw!' {J%i^79, dUHTAkB(|yAMlE3FQ|htJ<1@f)4GHlrO `yT &l80S'GûE$jZHXN``D`jsDAUϙCMbiA冮0<ʶkG+qjj[⒚H8(%0 \#seu s<|E!F\ VeD ypap ofBO*[M_ Ma> X[R$6#x4c0ѫ}o/**sp)κ^?';s-i#?( *MMcWո ONB#lһ@lm>vAثסZ>* EPdo'tZwDD=.DH xٕ3Eviz588Ծ Cj@U@4q*֘@:\r@ huv,uk+- =<\yͻW/璠Uj/tnP(=>ty3{EZ l͖C{j*깅_u10F[Vn:n0n&y鯽@ "YU}t9\:3QEN9"?3:FndRqN\*LL(s'ԩ'$*o,aI6*7;_NKY=c5m2gG^IWHШ)h.4{I-8.yAOZ٩`-~8Dq>N#r`iBkK?#,4,PFXZUyݲV;gіsW0 FE(i@Y?alL4!l]#h-QޢfҧW90q #' 2UTsir;hz3Z.{>ة?U1ig?ůNdկ .rx5M"̥CM>k?`>+\~Q}|kxr4.bx؉:lgݾت _-!$#vxv`lzAwQ']B1,nFXxiqk,6Y|氂s6p{}O^c鴪j_;nrg ]`Cn˅l9\3Ϭ~VYǩ,j-{lev 64]V~=6/eN >K|ދ> ?(G,?3jܴgfdmp ]nC]w4l'<?1̤U 8C:5*7ay2^\].$:c旐 public – digitalarpita.com https://digitalarpita.com Mon, 31 Aug 2026 12:06:25 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.8 Coronavirus disease 2019 https://digitalarpita.com/coronavirus-disease-2019-6/ Mon, 31 Aug 2026 12:06:24 +0000 https://digitalarpita.com/?p=1341 COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

]]> Coronavirus disease 2019 https://digitalarpita.com/coronavirus-disease-2019-5/ https://digitalarpita.com/coronavirus-disease-2019-5/#respond Mon, 27 Jul 2026 10:31:26 +0000 https://digitalarpita.com/?p=1323 COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

]]> https://digitalarpita.com/coronavirus-disease-2019-5/feed/ 0 Coronavirus disease 2019 https://digitalarpita.com/coronavirus-disease-2019-4/ Wed, 24 Jun 2026 00:59:33 +0000 https://digitalarpita.com/?p=1321 COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

]]> Coronavirus disease 2019 https://digitalarpita.com/coronavirus-disease-2019-3/ Tue, 19 May 2026 23:27:49 +0000 https://digitalarpita.com/?p=1316 COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

]]> Coronavirus disease 2019 https://digitalarpita.com/coronavirus-disease-2019-2/ Wed, 06 May 2026 11:26:16 +0000 https://digitalarpita.com/?p=994 COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

]]> Coronavirus disease 2019 https://digitalarpita.com/coronavirus-disease-2019/ Wed, 06 May 2026 10:44:10 +0000 https://digitalarpita.com/?p=991 COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

]]>